Vibcare Healthcare operates a 100,000-square-foot WHO-GMP-certified facility that manufactures tablets, capsules, oral liquids, and external preparations. The company serves over 1,000 pharmaceutical partners across multiple therapeutic segments, including cardiovascular, antidiabetics, gastroenterology, and antibiotics. Drug manufacturing companies in India are typically subject to regulatory scrutiny. Vibcare's infrastructure meets EU GMP and PIC/s audit standards, eliminating the compliance burden that keeps many brands from scaling effectively. This certification means international clients can source directly from India without having to navigate complex import protocols.

A company spokesperson explained the core tension: "Pharmaceutical brands want to grow quickly without building factories. They need a partner who handles regulatory documentation, quality control, and production scaling simultaneously. Most manufacturers make you choose between speed and compliance. We make that choice unnecessary. Our customers achieve market entry in months rather than years because we manage the technical complexity they fear most."

Vibcare's operational history demonstrates tangible capability. The company has approved over 1,500 formulations and achieved 750 regulatory approvals across domestic and international markets. The recent investment of Rs 40 crore in facility expansion demonstrates the company's commitment to long-term partnerships rather than transactional relationships. Drug manufacturing companies in India must balance growth with financial prudence. Vibcare's measured expansion suggests sustainable operations built on customer retention rather than marketing hype.

About Vibcare Healthcare

Vibcare Healthcare operates as a third-party pharmaceutical manufacturing partner based in Panchkula, Haryana. The company provides end-to-end contract manufacturing services for emerging and established pharmaceutical brands seeking WHO-GMP certified operations. Visit vibcarehealthcare.com for more information.